LRIG1 Rabbit Polyclonal Antibody
|
|
|||
| E-AB-90324-120uL | Elabscience Biotech | 120uL | 320 EUR |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-90324-200uL | Elabscience Biotech | 200uL | 530 EUR |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-90324-60uL | Elabscience Biotech | 60uL | 200 EUR |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-90324-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-63339-120uL | Elabscience Biotech | 120uL | 320 EUR |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-63339-200uL | Elabscience Biotech | 200uL | 530 EUR |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-63339-60uL | Elabscience Biotech | 60uL | 200 EUR |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-63339-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-12544-120uL | Elabscience Biotech | 120uL | 240 EUR |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-12544-200uL | Elabscience Biotech | 200uL | 399 EUR |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-12544-20uL | Elabscience Biotech | 20uL | 73 EUR |
|
Description: Unconjugated |
|||
|
|
|||
| E-AB-12544-60uL | Elabscience Biotech | 60uL | 143 EUR |
|
Description: Unconjugated |
|||
|
|
|||
| BT-AP10966-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
|
Description: The LRRs and the Ig-domains are each sufficient for EGFR/ERBB1 binding. This interaction is abolished only when these two domains are deleted.,Act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.,induction:By EGF.,Contains 17 LRR (leucine-rich) repeats.,Contains 3 Ig-like C2-type (immunoglobulin-like) domains.,subunit:Interacts with EGFR/ERBB1, ERBB2, ERBB3 and ERBB4.,tissue specificity:Widely expressed., |
|||
|
|
|||
| BT-AP10966-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
|
Description: The LRRs and the Ig-domains are each sufficient for EGFR/ERBB1 binding. This interaction is abolished only when these two domains are deleted.,Act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.,induction:By EGF.,Contains 17 LRR (leucine-rich) repeats.,Contains 3 Ig-like C2-type (immunoglobulin-like) domains.,subunit:Interacts with EGFR/ERBB1, ERBB2, ERBB3 and ERBB4.,tissue specificity:Widely expressed., |
|||
|
|
|||
| BT-AP10966-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
|
Description: The LRRs and the Ig-domains are each sufficient for EGFR/ERBB1 binding. This interaction is abolished only when these two domains are deleted.,Act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.,induction:By EGF.,Contains 17 LRR (leucine-rich) repeats.,Contains 3 Ig-like C2-type (immunoglobulin-like) domains.,subunit:Interacts with EGFR/ERBB1, ERBB2, ERBB3 and ERBB4.,tissue specificity:Widely expressed., |
|||
|
|
|||
| BS74713 | Bioworld Biotech | 50ul | 358 EUR |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
|
|
|||
| E11-202904 | EnoGene | 100ug/100ul | 225 EUR |
|
Description: Available in various conjugation types. |
|||
|
|
|||
| JOT-AP10966-100ul | Jotbody | 100ul | 220 EUR |
|
|
|||
| JOT-AP10966-50ul | Jotbody | 50ul | 144 EUR |
|
|
|||
| E44H10511 | EnoGene | 100ul | 255 EUR |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
|
|
|||
| E912027 | EnoGene | 100ul | 225 EUR |
|
Description: Available in various conjugation types. |
|||
|
|
|||
| MBS2547628-006mL | MyBiosource | 0.06mL | 190 EUR |
|
|
|||
| MBS2547628-012mL | MyBiosource | 0.12mL | 265 EUR |
|
|
|||
| MBS2547628-02mL | MyBiosource | 0.2mL | 415 EUR |
|
|
|||
| MBS2547628-5x02mL | MyBiosource | 5x0.2mL | 1835 EUR |
|
|
|||
| MBS2524774-002mL | MyBiosource | 0.02mL | 135 EUR |
|
|
|||
| MBS2524774-006mL | MyBiosource | 0.06mL | 190 EUR |
|
|
|||
| MBS2524774-012mL | MyBiosource | 0.12mL | 265 EUR |
|
|
|||
| MBS2524774-02mL | MyBiosource | 0.2mL | 415 EUR |
|
|
|||
| MBS2524774-5x02mL | MyBiosource | 5x0.2mL | 1835 EUR |
|
|
|||
| MBS9130808-002mL | MyBiosource | 0.02mL | 200 EUR |
|
|
|||
| MBS9130808-005mL | MyBiosource | 0.05mL | 255 EUR |
|
|
|||
| MBS9130808-01mL | MyBiosource | 0.1mL | 345 EUR |
|
|
|||
| MBS9130808-02mL | MyBiosource | 0.2mL | 545 EUR |
|
|
|||
| MBS9130808-5x02mL | MyBiosource | 5x0.2mL | 2265 EUR |
|
|
|||
| MBS9131947-002mL | MyBiosource | 0.02mL | 200 EUR |
|
|
|||
| MBS9131947-005mL | MyBiosource | 0.05mL | 255 EUR |
|
|
|||
| MBS9131947-01mL | MyBiosource | 0.1mL | 345 EUR |
|
|
|||
| MBS9131947-02mL | MyBiosource | 0.2mL | 545 EUR |
|
|
|||
| MBS9131947-5x02mL | MyBiosource | 5x0.2mL | 2265 EUR |
|
|
|||
| MBS8567064-01mL | MyBiosource | 0.1mL | 305 EUR |
|
|
|||
| MBS8567064-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 565 EUR |
|
|
|||
| MBS8567064-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 565 EUR |
|
|
|||
| MBS8567064-01mLAF610 | MyBiosource | 0.1mL(AF610) | 565 EUR |
|
|
|||
| MBS8567064-01mLAF635 | MyBiosource | 0.1mL(AF635) | 565 EUR |
|
|
|||
| MBS8532262-01mg | MyBiosource | 0.1mg | 305 EUR |
|
|
|||
| MBS8532262-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 465 EUR |
|
|
|||
| MBS8532262-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 465 EUR |
|
|
|||
| MBS8532262-01mLAF610 | MyBiosource | 0.1mL(AF610) | 465 EUR |
|
|
|||
| MBS8532262-01mLAF635 | MyBiosource | 0.1mL(AF635) | 465 EUR |
|
|
|||
| RD76340A-120uL | Reddot Biotech | 120μL | 360 EUR |
|
Description: Leucine-rich repeats and immunoglobulin-like domains protein 1is aproteinthat in humans is encoded by theLRIG1gene.It encodes atransmembrane proteinthat has been shown to interact with receptor tyrosine kinases of theEGFR-family,METandRET. Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation. |
|||
|
|
|||
| RD76340A-200uL | Reddot Biotech | 200μL | 630 EUR |
|
Description: Leucine-rich repeats and immunoglobulin-like domains protein 1is aproteinthat in humans is encoded by theLRIG1gene.It encodes atransmembrane proteinthat has been shown to interact with receptor tyrosine kinases of theEGFR-family,METandRET. Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation. |
|||
|
|
|||
| RD76340A-20uL | Reddot Biotech | 20μL | 109.5 EUR |
|
Description: Leucine-rich repeats and immunoglobulin-like domains protein 1is aproteinthat in humans is encoded by theLRIG1gene.It encodes atransmembrane proteinthat has been shown to interact with receptor tyrosine kinases of theEGFR-family,METandRET. Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation. |
|||
|
|
|||
| RD76340A-60uL | Reddot Biotech | 60μL | 214.5 EUR |
|
Description: Leucine-rich repeats and immunoglobulin-like domains protein 1is aproteinthat in humans is encoded by theLRIG1gene.It encodes atransmembrane proteinthat has been shown to interact with receptor tyrosine kinases of theEGFR-family,METandRET. Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation. |
|||
LRIG1 Rabbit Polyclonal Antibody